Outcomes of acute myeloid leukemia with KMT2A (MLL) rearrangement: a multicenter study of TROPHY group

Blood Cancer J. 15, 84 (2025). doi.org/10.1038/s414...
#astct #aml #ash

Combination of disease burden before allo-HSCTand early post-transplant MRD predicts survival in AML

Ann Hematol (2025). doi.org/10.1007/s002...
#lls #astct #aml

GVHD prophylaxis in matched related HSCT: Why PTCy can be recommended a study by the EBMT transplant complications working party

Leukemia (2025). doi.org/10.1038/s413...
#astct #lls #ash

Teduglutide for treatment-refractory severe GI aGVHD
www.nature.com/articles/s41...
#astct #gvhd

Less frequent complications following CAR T-cell: HLH, GVHD, TMA, coag disorders and 2nd malignancies: recommendations from the EBMT Practice Harmonization and Guidelines Committee

Bone Marrow Transplant (2025). doi.org/10.1038/s414...

Improved post-transplant outcomes for elderly AML with FLU/BU4 rather than conventional MAC regimens.

Bone Marrow Transplant (2025). doi.org/10.1038/s414...
#LLS #astct #AML

ASCT for R/R Large B Cell Lymphoma: Multicenter GETH-TC/GELTAMO Study

doi.org/10.1182/bloo...
#lls #astct #bmt

Allo HSCT Using FLU-BU3 and ATG With Strategic Donor Lymphocyte Infusion in Older Patients With Myeloid Malignancy. www.scilit.com/publications...

HSCT & quizartinib in newly diagnosed AML FLT-3 ITD: the QuANTUM-First trial

doi.org/10.3324/haem...
#AML #ASTCT